OGT to Present at International Workshop on the Search for New IVD Biomarkers

June 17, 2010 - PRLog -- Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has been invited to present at the British In Vitro Diagnostics Association (BIVDA) Trilateral Workshop: “Role and significance of in vitro diagnostics in the healthcare systems of the future”. Hosted at the French Embassy in Berlin from June 16 - 17, the workshop will consist of a series of sessions and chaired discussions, presenting state-of-the-art research in in vitro diagnostics (IVD) applications. On June 17, Dr. John Anson, Vice President of Biomarker Discovery at OGT, will speak on ‘Screening for novel oncology biomarker panels using both DNA and protein microarrays’.

Dr. Anson’s presentation will explore how knowledge of the human genome and proteome can be used to design DNA and protein microarrays to screen for markers of cancers and autoimmune diseases. Dr. Anson will also present the results from an internal study, demonstrating the ability to identify a set of biomarkers in serum samples that can distinguish between cancerous and non-cancerous prostate cells, with sensitivity and specificity levels above 90%. Such advances will lead to the generation of more accurate diagnostic tests with greater discriminatory power, offering improved patient outcomes.

For more information about OGT’s biomarker discovery technologies, visit www.ogt.co.uk.

For further information, please contact:
Oxford Gene Technology, Begbroke Science Park, Sandy Lane, Yarnton, Oxford OX5 1PF
T: +44 (0) 1865 856826 ;
F: +44 (0) 1865 848684 ;
E: products@ogt.co.uk
W: www.ogt.co.uk

# # #

About Alto Marketing
Established in 2002, We’re marketers with a solid science foundation specialising in scientific and healthcare marketing. We put together campaigns to suit our clients’ requirements such as PR to a fully integrated campaign.